Catalyst Pharmaceuticals (CPRX) Shares Outstanding (2010 - 2026)

Catalyst Pharmaceuticals (CPRX) has 17 years of Shares Outstanding data on file, last reported at $122.2 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Outstanding changed 0.18% year-over-year to $122.2 million; the trailing twelve-month figure through Mar 2026 stood at $122.2 million (changed 0.18% YoY), and the FY2025 full-year result was $122.5 million, up 1.35% from the prior year.
• Shares Outstanding for Q1 2026 stood at $122.2 million, roughly flat from $122.5 million in the prior quarter.
• Across five years, Shares Outstanding topped out at $123.3 million in Q3 2025 and bottomed at $102.7 million in Q2 2022.
• The 5-year median for Shares Outstanding is $118.0 million (2024), against an average of $113.5 million.
• The widest annual swing landed in 2022, when Shares Outstanding slipped 0.82%; it then advanced 12.84% in 2024.
• A 5-year view of Shares Outstanding shows it stood at $105.3 million in 2022, then gained by 1.77% to $107.1 million in 2023, then rose by 12.84% to $120.9 million in 2024, then gained by 1.35% to $122.5 million in 2025, then dropped by 0.27% to $122.2 million in 2026.
• The last three Shares Outstanding figures came in at $122.2 million (Q1 2026), $122.5 million (Q4 2025), and $123.3 million (Q3 2025), per Business Quant data.

Peer Comparison